Takashi Nakano, 3 Kazunobu Ouchi 3 and Niro Okimoto 1 Mycoplasma pneumoniae is one of the major causative pathogens of community-acquired pneumonia (CAP) [1] . It is well known that some cases develop into severe pneumonia [2] [3] [4] [5] [6] [7] . Several studies have demonstrated that an excessive host cellular response, especially with respect to IL-18, plays a critical role in the development of serious pulmonary manifestations [8] [9] [10] [11] [12] [13] . Thus, immunosuppressive therapy, such as with corticosteroids, down-regulates the cell-mediated immune responses and has been shown to have a profound beneficial effect [2] [3] [4] [5] [6] [7] [11] [12] [13] [14] . On this point, little information is available concerning the histology of M. pneumoniae pneumonia in humans because pneumonia severity is usually mild, and the histological findings of severe M. pneumoniae pneumonia have mainly been investigated using autopsy specimens. ; arterial oxygen pressure/fraction of inspired oxygen ratio 250; multilobar infiltrates; blood urea nitrogen level !20 mg dl
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The study protocol was approved by the Ethics Committee of Kawasaki Medical School.
We identified the causative microorganisms by various methods, such as Gram stain, cultures, polymerase chain reaction (PCR), urinary antigen tests and serological tests, to identify the pathogens responsible for pneumonia, as described previously [13] . M. pneumoniae pneumonia was diagnosed using a positive culture or PCR result, or a fourfold increase in antibody titer [13] . Cultivation of M. pneumoniae was carried out using pleuropneumonia-like organism broth (Difco, Detroit, MI, USA). DNAwas then extracted using a QIAamp DNA mini kit (QIAGEN K.K., Tokyo, Japan) in accordance with the manufacturer's instructions. M. pneumonia DNA was detected using realtime PCR targeting a conserved part of the gene encoding P1 adhesin. Antibodies to M. pneumoniae were measured using a particle agglutination test (Serodia-Myco II kit, Fujirebio, Tokyo, Japan).
During the study period, a total of 18 patients (mean age 34.8 years; age range 21-56 years; 7 males and 11 females) with severe M. pneumoniae pneumonia who underwent bronchoscopic examination before corticosteroid administration were analysed. Cases of mixed infection with M. pneumoniae and other microorganisms were excluded from this study. All severe pneumonia patients who were refractory to appropriate antibiotic therapy had methylprednisolone pulse therapy administered at a dose of 1 g/day for 3 days. Then, oral prednisolone 40 mg/day was administered, with patients being weaned off over 1 to 2 weeks. After corticosteroid administration, the clinical and radiographic findings for all patients improved rapidly. IL-18 serum levels were measured in six patients before and after the use of corticosteroids. The serum IL-18 levels, which were 618-1680 pg ml À1 at commencement of administration of corticosteroids, decreased to <500 pg ml À1 in all patients. No severe pneumonia patients showed worsening of clinical and radiographic findings after the discontinuation of prednisolone, and no patients showed further complications associated with infection.
The histological findings for 18 patients with severe M. pneumoniae pneumonia are summarized in Table 1 . Thickened edematous alveolar walls with infiltration of lymphocytes was the most frequently observed histological pattern, followed by intra-alveolar exudate with moderate to massive macrophage and polypoid organizing tissue in the alveolar space and/or the lumen of respiratory bronchioles. Bronchiolar samples were collected in six patients by bronchoscopic examination. All patients demonstrated acute bronchiolitis with prominent lymphocyte infiltration in the bronchiolar walls.
Histopathologically, M. pneumoniae pneumonia is characterized by acute cellular bronchiolitis and peribronchial and perivascular interstitial opacities [1, 15] . Bronchiolitis obliterans has also been described [1, 15] . These histopathological findings closely reflected the high-resolution computed tomography findings for the chest, which indicated a combination of bronchial wall thickening and centrilobular nodules. Our results were similar to those for previous studies and showed the non-specific findings observed in pneumonia of other infectious aetiologies. Our study included a larger number of cases (N=18) to allow the calculation of the frequency of each histological finding. In addition to acute cellular bronchiolitis, thickened edematous alveolar walls with infiltration of lymphocytes was thought to play an important role in the development of hypoxia.
Pulmonary injury associated with severe M. pneumoniae pneumonia was previously thought to be due to an excessive activated cell-mediated immune response -especially with respect to IL-18 -to pathogens rather than to direct microbial damage [1, 10] . If severe M. pneumoniae pneumonia is an immune-mediated disease, immune-suppressive therapy is a rational approach. In several studies, a combination of corticosteroids and antibiotic therapy demonstrated satisfactory clinical effects and reduced serum IL-18 levels in patients with severe M. pneumoniae pneumonia [11] [12] [13] . IL-18 is a macrophage-derived cytokine. Our histological finding that macrophages are enriched in infiltrating cells can explain the fact that IL-18 increases in patients with severe M. pneumoniae pneumonia. The use of corticosteroids combined with antibiotic therapy to decrease the inflammatory response -with dramatic beneficial effectshas also been demonstrated in several studies [2] [3] [4] [5] [6] [7] 14] . Our histological study indicated that corticosteroids might be effective against oedema of the alveolar, bronchial and bronchiolar walls, polypoid organizing tissue and cellular bronchiolitis with lymphocytic infiltration. In fact, some histological studies have demonstrated submucosal or interstitial infiltration by lymphocytes and/or mononuclear cells in the most severe cases of bronchiolitis [16] [17] [18] [19] [20] . Although neutrophilic inflammation into the alveolar spaces must be a hallmark of ordinary cases of M. pneumoniae pneumonia [15] , neither diffuse alveolar damage nor intra-alveolar neutrophilic exudates were observed in the patients in our study. Whether this difference in infiltrating cells represents a fundamental difference in pathophysiology or is a consequence of a simple difference in the timing of sample collection for the same pathophysiology remains to be elucidated.
In this study we did not try to demonstrate M. pneumoniae antigens in tissue by immunohistochemistry or the specialized structure of M. pneumoniae by electron microscopy; therefore, further studies are needed.
In conclusion, we investigated histological findings in patients with severe M. pneumoniae pneumonia who responded to corticosteroid therapy, and found thickened oedematous alveolar and bronchiolar walls with infiltration of macrophages, lymphocytes and acute cellular bronchiolitis as the major histological findings in severe M. pneumoniae pneumonia. Our study validated further histological studies to explore which patients with severe M. pneumoniae pneumonia might benefit most from corticosteroid treatment, and at what stage of illness the treatment is most effective.
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